Microplate Alamar Blue Assay for Staphylococcus epidermidis Biofilm Susceptibility Testing
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Biofilms are at the root of many infections largely because they are much more antibiotic resistant than their planktonic counterparts. Antibiotics that target the biofilm phenotype are desperately needed, but there is still no standard method to assess biofilm drug susceptibility. Staphylococcus epidermidis ATCC 35984 biofilms treated with eight different approved antibiotics and five different experimental compounds were exposed to the oxidation reduction indicator Alamar blue for 60 min, and reduction relative to untreated controls was determined visually and spectrophotometrically. The minimum biofilm inhibitory concentration was defined as ≤50% reduction and a purplish well 60 min after the addition of Alamar blue. All of the approved antibiotics had biofilm MICs (MBICs) of >512 μg/ml (most >4,096 μg/ml), and four of the experimental compounds had MBICs of ≤128 μg/ml. The experimental aaptamine derivative hystatin 3 was used to correlate Alamar blue reduction with 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2 H -tetrazolium-5-carboxanilide (XTT) reduction and viable counts (CFU/ml) for S. epidermidis ATCC 35984, ATCC 12228, and two clinical isolates. For all four strains, Alamar blue results correlated well with XTT ( r = 0.83 to 0.97) and with CFU/ml results ( r = 0.85 to 0.94). Alamar blue's stability and lack of toxicity allowed CFU/ml to be determined from the same wells as Alamar blue absorbances. If the described method of microplate Alamar blue biofilm susceptibility testing, which is simple, reproducible, cost-effective, nontoxic, and amenable to high throughput, is applicable to other important biofilm forming species, it should greatly facilitate the discovery of biofilm specific agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 1×
“These data are consistent with previous reports of many-fold increases in drug resistance of biofilm versus planktonic-grown strains (11).”
ResultChristensen, G. D., Simpson, W. A., Younger, J. J., Baddour, L. M., Barrett, F. F., Melton, D. M., & Beachey, E. H. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.6.996-1006.1985 · Cited by 2,255
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Collins, L., & Franzblau, S. G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1004 · Cited by 1,599
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578 · cited 1×
“For fungi, the most common method is an XTT [2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] reduction assay (1, 8, 25), and this method has also been used for bacterial biofilms (1).”
MethodWalters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
A NEW FLUOROMETRIC ASSAY FOR CYTOTOXICITY MEASUREMENTS IN-VITRO
PAGE, B., PAGE, M., & NOEL, C. (1993) · International Journal of Oncology · doi:10.3892/ijo.3.3.473 · Cited by 583
Coagulase-Negative Staphylococci: Pathogens Associated with Medical Progress
Rupp, M. E., & Archer, G. L. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.2.231 · Cited by 487
Mixed species biofilms of Candida albicans and Staphylococcus epidermidis
ADAM, B., BAILLIE, G. S., & DOUGLAS, L. J. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-4-344 · Cited by 374
Uses and Limitations of the XTT Assay in Studies of Candida Growth and Metabolism
Kuhn, D. M., Balkis, M., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.506-508.2003 · Cited by 339
Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm
Dunne, W. M., Mason, E. O., & Kaplan, S. L. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.12.2522 · Cited by 255
Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro
Amorena, B., Gracia, E., Monzón, M., Leiva, J., Oteiza, C., Pérez, M., Alabart, J.-L., & Hernández-Yago, J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.1.43 · Cited by 247
Balaban, N., Giacometti, A., Cirioni, O., Gov, Y., Ghiselli, R., Mocchegiani, F., Viticchi, C., Del Prete, M. S., Saba, V., Scalise, G., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/345879 · Cited by 173
[48] Candida biofilms and their susceptibility to antifungal agents
Baillie, G. S., & Douglas, L. J. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)10050-8 · Cited by 161
Pfaller, M. A., & Barry, A. L. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1992-1996.1994 · Cited by 160
Sweeney, M. T., & Zurenko, G. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1902-1906.2003 · Cited by 96
[16] Robbins device in biofilm research
Kharazmi, A., Giwercman, B., & Høiby, N. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)10018-1 · Cited by 92
A new Alamar Blue viability assay to rapidly quantify oligodendrocyte death
Back, S. A., Khan, R., Gan, X., Rosenberg, P. A., & Volpe, J. J. (1999) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(99)00062-x · Cited by 90
Tetracycline Rapidly Reaches All the Constituent Cells of Uropathogenic Escherichia coli Biofilms
Stone, G., Wood, P., Dixon, L., Keyhan, M., & Matin, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2458-2461.2002 · Cited by 89
Polonio, R. E., Mermel, L. A., Paquette, G. E., & Sperry, J. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3262-3266.2001 · Cited by 86
To, W. K., Fothergill, A. W., & Rinaldi, M. G. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2660-2664.1995 · Cited by 78
Labthavikul, P., Petersen, P. J., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3967-3969.2003 · Cited by 55
Cited by
Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates
Peeters, E., Nelis, H. J., & Coenye, T. (2008) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2007.11.010 · Cited by 1,143
Critical review on biofilm methods
Azeredo, J., Azevedo, N. F., Briandet, R., Cerca, N., Coenye, T., Costa, A. R., Desvaux, M., Di Bonaventura, G., Hébraud, M., Jaglic, Z., et al. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1208146 · Cited by 1,045
Ribeiro, M., Monteiro, F. J., & Ferraz, M. P. (2012) · Biomatter · doi:10.4161/biom.22905 · Cited by 824
In vitro and in vivo model systems to study microbial biofilm formation
Coenye, T., & Nelis, H. J. (2010) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2010.08.018 · Cited by 463
Bazargani, M. M., & Rohloff, J. (2016) · Food Control · doi:10.1016/j.foodcont.2015.09.036 · Cited by 403
Metadata
- Authors
- Pettit, R. K., Weber, C. A., Kean, M. J., Hoffmann, H., Pettit, G. R., Tan, R., Franks, K. S., & Horton, M. L.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2005-07
- Volume
- 49
- Issue
- 7
- Pages
- 2612-2617
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2131534333
- Cited by
- 334
- References
- 26
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.